Raub Brock Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,100
| Closed | -$902K | – | 68 |
|
|
2023
Q4 | $902K | Hold |
10,100
| – | – | 0.19% | 35 |
|
|
2023
Q3 | $738K | Hold |
10,100
| – | – | 0.15% | 34 |
|
|
2023
Q2 | $840K | Hold |
10,100
| – | – | 0.16% | 30 |
|
|
2023
Q1 | $770K | Buy |
10,100
+6,000
| +146% | +$457K | 0.15% | 30 |
|
|
2022
Q4 | $340K | Buy |
4,100
+600
| +17% | +$49.8K | 0.07% | 44 |
|
|
2022
Q3 | $278K | Buy |
+3,500
| New | +$278K | 0.06% | 52 |
|